|
|
 |
HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
INVOKAMET Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
IBSRELA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|